Lenalinomide plus rituximab for elderly patients with DLBCL, platelet GP6-mediated neutrophil recruitment in acute lung injury, and the role of AXL3 in mantle cell lymphoma.
This episode covers a phase 2 study on lenalinomide plus rituximab for elderly DLBCL patients. It also explores platelet GP6-mediated neutrophil recruitment in acute lung injury and a new AXL3 isoform in mantle cell lymphoma.